Alnylam Pharma (ALNY) Tops Q3 EPS by 8c
Get Alerts ALNY Hot Sheet
Price: $144.41 -0.52%
EPS Growth %: -6.6%
Financial Fact:
Research and development: 83.17M
Today's EPS Names:
MAXN, CSTR, ACU, More
EPS Growth %: -6.6%
Financial Fact:
Research and development: 83.17M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Alnylam Pharma (NASDAQ: ALNY) reported Q3 EPS of ($1.58), $0.08 better than the analyst estimate of ($1.66). Revenue for the quarter came in at $125.9 million versus the consensus estimate of $120.75 million.
For earnings history and earnings-related data on Alnylam Pharma (ALNY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- American Express (AXP) down despite beating Q1 estimates on top and bottom lines
- Wipro (WIT) Tops Q1 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!